September 17, 2018

With Senate Set To Vote On Major Legislation To Address Opioid Crisis, Gillibrand Makes Final Push For Funding To Help New York State Combat Opioid Epidemic, Increase Funding For Prescription Drug Monitoring Programs That Help Prevent Drug Abuse & Prescription Fraud

New York’s Prescription Drug Monitoring Program Has Helped Reduce Doctor Shopping and Prescription Opioid Abuse by 90 Percent Since 2013, But New York Doesn’t Have the Data It Needs from Half of States Across the Country to Help Prevent Opioid Addiction; Gillibrand Called on Colleagues to Support Funding to Allow Every State Across the Country to Share Critical Data That Is Proven to Cut Down on Opioid Abuse

Harrison, NY – U.S. Senator Kirsten Gillibrand today visited St. Vincent’s Hospital Westchester, a Division of St. Joseph’s Medical Center, in Harrison to push for funding to combat the opioid epidemic and support prescription drug monitoring programs that help prevent opioid abuse and prescription fraud. Gillibrand was joined by U.S. Representative Nita Lowey, Westchester County Executive George Latimer, and community leaders. The Senate is expected to vote on the Opioid Crisis Response Act this week, a major legislative package that would create new programs and funding streams to prevent and respond to the opioid epidemic.

The Opioid Crisis Response Act is a new legislative package that reauthorizes and improves existing programs at the Department of Health and Human Services (HHS) and the Department of Justice (DOJ), and creates new programs and funding opportunities to support federal, state, and local efforts to prevent and respond to the opioid crisis. Gillibrand has been fighting for the package to include language and funding to support programs in New York State and across the country that help prevent opioid abuse and prescription fraud, such as the I-STOP Prescription Drug Monitoring Program (PDMP) used in New York State.

“New York State has been hit hard by the opioid epidemic, and Congress should be doing everything it can to help our communities fight back against this crisis and prevent abuse of these highly addictive drugs,” said Senator Gillibrand. “As the Senate prepares to vote on a major legislative package that could deliver millions of dollars in resources to our local communities, I’m fighting to pass provisions to help support and fund Prescription Drug Monitoring Programs like I-STOP that help prevent abuse and prescription fraud, and I’m working to ensure that this legislation gives towns and cities across New York the federal funding they need to support their work to combat the opioid epidemic.”

“Opioid addiction is a national emergency, and every level of government must work with stakeholders, including health officials, law enforcement, families of those struggling with addiction, and survivors to truly combat this threat, so that fewer people face the pain of addiction or the horror of burying a loved one gone too soon,” said Congresswoman Lowey. “As the Ranking Member of the House Appropriations Committee, I was proud to negotiate $4.4 billion in federal investments on substance abuse for Fiscal Year 2019, including prevention, treatment, health workforce training, and research, and I will continue fighting to send additional resources to New York to combat this epidemic.”

Westchester County Executive George Latimer said, “Westchester has not been spared of deleterious effect of opioid addiction on our families and communities - we all have family members, neighbors or friends who have been impacted. It is imperative to recognize the complexity of the epidemic and to respond with a multi-faceted approach, including a coordinated focus on Education, Prevention, Intervention/Treatment, and Public Safety. I thank Senator Gillibrand for taking action and working with us here in Westchester to help ensure no one is left behind.”

“We welcome the critical tools provided by this federal legislation. It will help turn the tide on this terrible opioid epidemic and support the recovery of the thousands of individuals who turn to us and our colleagues for addiction treatment services,” said David Gerber, Director of St. Vincent’s Outpatient and Addiction Services.

The Opioid Crisis Response Act would provide federal assistance and funding to states to improve their PDMPs to encourage the sharing of data between states and implement other prevention strategies that have proven to be effective in combatting the opioid epidemic. New York’s prescription drug monitoring program, I-STOP, has been in effect since 2013 and has helped reduce “doctor-shopping” — when people go to multiple doctors to get prescriptions for opioid pills or any other controlled substance — by 90 percent. As of March 2018, New York is currently sharing with and receiving prescription drug monitoring data from 25 states and the District of Columbia. Gillibrand fought for the Opioid Crisis Response Act to provide critical support for New York and other states to expand prescription drug monitoring, which is crucial to combatting the opioid crisis and plays a critical role in helping to improve opioid and clinical prescribing practices, protect at-risk patients, and prevent fraud.

The Opioid Crisis Response Act that Gillibrand is fighting to pass would do the following:

  • Improve Prescription Drug Monitoring Programs by
  • Providing new federal support for states and localities to improve their PDMPs in order to encourage data-sharing and implement other evidence-based prevention strategies related to controlled substances.
  • Reauthorizing a grant program at HHS, which provides funding to states to develop, maintain, or improve PDMPs.
  • Directing HHS and the Attorney General (AG) of the United States to conduct a study on the effect of federal and state laws and regulations that limit the length, quantity, or dosage of opioid prescriptions.
  • Directing the HHS Secretary and the AG to create a plan to educate and train medical practitioners on best practices for prescribing controlled substances.
  • Support Prescribing Limits by:
  • Reauthorize the Following Programs:
    • Drug-Free Communities (DFC) Program
      • DFC is a grant program administered by the Office of National Drug Control Policy that works to prevent youth substance abuse and reduce the demand for illicit narcotics at a community level.
    • High-Intensity Drug Trafficking Area Program (HIDTA):
      • HIDTA provides funding for federal, state, and local task forces to improve intelligence-sharing initiatives, support drug use prevention and drug treatment initiatives, and provide assistance to law enforcement to reduce drug trafficking.
    • Drug Court Program:
      • The Drug Court Programs provide offenders with substance abuse and mental health services with rehabilitation, screening services, and monitoring by the judicial system as an alternative to traditional incarceration.